First onset and early symptomatology of schizophrenia

Angermeyer MC, Kühn L (1988) Gender differences in age at onset of schizophrenia. Eur Arch Psychiatr Neurol Sci 237:351–364

Birnbaum K (1923) Der Aufbau der Psychose. Grundzüge der psychiatrischen Strukturanalyse. Springer, Berlin

Castle DJ, Murray RM (1991) The neurodevelopmental basis of sex differences in schizophrenia. Psychol Med 21, 565–575

Dilling H, Weyerer S (1978) Epidemiologie psychischer Störungen und psychiatrische Versorgung. Urban & Schwarzenberg, München

DiPaolo T, Falardeau P (1985) Modulation of brain and pituitary dopamine receptors by estrogens and prolactin. Prog. Neuro-Psychopharmacol Biol Psychiat 9:473–480

Dohrenwend BP (1990) Strategies for psychosocial research into the causes of schizophrenia. In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia II. Springer, Berlin Heidelberg, pp 397–407

Dunham HW (1965) Community and schizophrenia: an epidemiological analysis. Wayne State University Press, Detroit

Fätkenheuer B, Riecher-Rössler A, Löffler W, Häfner H (1992). Social biography in schizophrenic patients. Poster presented at the AEP Section Committee Meeting in Zürich, 8–10th April, 1991

Fields JZ, Gordon JH (1982) Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics. Life Sciences 30:229–234

Häfner H, Maurer K (1991) Are there two types of schizophrenia? In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer-Verlag, Berlin, Heidelberg, pp 134–159

Häfner H, Riecher A, Maurer K, Löffler W, Munk-Jorgensen P, Strömgren E (1989) How does gender influence age at first hospitalization for schizophrenia? Psychol Med 19:903–918

Häfner H, Behrens S, Vry J de, Gattaz WF, Löffler W, Maurer K, Riecher-Rössler A (1991a) Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogen. Nervenheilkunde 10:154–163

Häfner H, Maurer K, Löffler W, Riecher-Rössler A (1991b) Schizophrenie und Lebensalter. Nervenarzt 62:536–548

Häfner H, Riecher A, Maurer K, Fätkenheuer B, Löffler W, an der Heiden W, Munk-Jørgensen P, Strömgren E (1991d) Geschlechtsunterschiede bei schizophrenen Erkrankungen. Fortschr Neural Psychiat 59:343–360

Häfner H, Maurer K, Löffler W, Riecher-Rössler A (1992a) The influence of age and sex on onset and early course in schizophrenia. Br J Psychiatry (accepted for publication)

Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, an der Heiden W (1992b) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research 6:209–223

Hambrecht M, Maurer K, Häfner H (1992) Transnational stability of gender differences in schizophrenia? An analysis based on the WHO Study on Determinants of Outcome of Severe Mental Disorders. Eur Arch Psychiatr Clin Neurosci (in press)

Hruska RE (1986) Elevation of striatal dopamine receptors by estrogen: Dose and time studies. J Neurochem 47:1908–1915

Jablensky A (1987) Multicultural studies and the nature of schizophrenia: a review. J R Soc Med 80:162–167

Kraepelin E (1909–1905) Psychiatrie (Bd. 1–4). Barth: Leipzig

Labrie F, Beaulieu M, Caron M, Raymond V (1978) The adenohypophyseal dopamine receptors, specificity and modulation of its activity by estradiol. In: Robin C, Harter M (eds) Proc Int Symp on Prolactin. Elsevier, Amsterdam, pp 121–136

Lewine RRJ (1988) Gender and schizophrenia. In: Nasrallah HA (ed) Handbook of schizophrenia. Vol. 3. Elsevier, Amsterdam, pp 379–397

Maurer K, Häfner H (1991) Dependence, independence or interdependence of positive and negative symptoms. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer-Verlag, Berlin Heidelberg New York, pp 160–182

Murray RM, Lewis SW (1987) Is schizophrenia a neurodevelopmental disorder? Br Med J 295:681–682

Raymond V, Beaulieu M, Labarie F, Bossier JR (1978) Potent antidopaminergic activity of estradiol at the pituitary level of prolactin release. Science 200:1173–1175

Riecher-Rössler A, Häfner H, Maurer K, Stummbaum M, Schmidt R (1992) Schizophrenic symptomatology varies with serum estradiol levels during menstrual cycle. Schizophrenia Research 6 (Special Issue):114

Salokangas RKR, Stengard E, Räkköläinen V, Kaljonen IHA (1987) New schizophrenic patients and their families (English Summary). In: Reports of Psychiatria Fennica, No. 78: Skitsofreninan tutkimuksen, hoidon ja kuntoutuksen valtakunnallinen kehittämisohjelma. Foundation for psychiatric research in Finland, Helsinki

Seeman M (1982) Gender differences in schizophrenia. Can J Psychiatry 27:107–112

Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16:185–194

Shepherd M, Watt D, Falloon I, Smeeton N (1989) The natural history of schizophrenia: a five-year follow-up study of schizophrenics. Psychological Medicine Monograph Supplement 15. Cambridge University Press, London

Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symtoms: An Instruction Manual for the PSE and Catego Program. Cambridge University Press, London